Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial

Florence Ader, Maude Bouscambert-Duchamp, Maya Hites, Nathan Peiffer-Smadja, Julien Poissy, Drifa Belhadi, Alpha Diallo, Christelle Delmas, Juliette Saillard, Aline Dechanet, Claire Fougerou, Minh-Patrick Lê, Gilles Peytavin, Noémie Mercier, Priyanka Velou, Sarah Tubiana, Xavier Lescure, Emmanuel Faure, Saad Nseir, Jean-Christophe Richard, Florent Wallet, François Goehringer, Benjamin Lefèvre, Antoine Kimmoun, François Raffi, Benjamin Gaborit, Jean Reignier, Jean-Philippe Lanoix, Claire Andrejak, Yoann Zerbib, Firouzé Bani-Sadr, Bruno Mourvilliers, François Danion, Yvon Ruch, Raphaël Clere-Jehl, Vincent Le Moing, Kada Klouche, Karine Lacombe, Guillaume Martin-Blondel, Fanny Vardon-Bounes, André Cabié, Jean-Marie Turmel, Lionel Piroth, Mathieu Blot, Élisabeth Botelho-Nevers, Amandine Gagneux-Brunon, Guillaume Thiery, François Bénézit, Rostane Gaci, Joy Mootien, Sébastien Gallien, Denis Garot, Kevin Bouiller, Loïc Epelboin, Stéphane Jauréguiberry, View ORCID ProfileAlexandre Gaymard, Gil Verschelden, Sandra Braz, Joao Miguel Ferreira Ribeiro, Michael Joannidis, Thérèse Staub, Antoine Altdorfer, Richard Greil, Alexander Egle, Jérémie Guedj, Marion Noret, Roberto Roncon-Albuquerque, Jose-Artur Paiva, Bruno Lina, Dominique Costagliola, Yazdan Yazdanpanah, Charles Burdet, France Mentré
doi: https://doi.org/10.1101/2022.03.30.22273206
Florence Ader
1Hospices Civils de Lyon, Hôpital de la Croix-Rousse, Département des Maladies Infectieuses et Tropicales, F-69004, Lyon, France
2Université Claude Bernard Lyon 1, CIRI, INSERM U1111, CNRS UMR5308, ENS Lyon, F-69372, Lyon, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: florence.ader@chu-lyon.fr
Maude Bouscambert-Duchamp
3Hospices Civils de Lyon, Laboratoire de Virologie, Institut des Agents Infectieux de Lyon, Centre National de Référence des virus respiratoires France Sud, F-69317, Lyon, France
4Université Claude Bernard Lyon 1, Virpath, CIRI, INSERM U1111, CNRS UMR5308, ENS Lyon, F-69372, Lyon, France
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maya Hites
5Cliniques Universitaires de Bruxelles – Hôpital Érasme, Université Libre de Bruxelles, Clinique des maladies infectieuses, Brussels, Belgium
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathan Peiffer-Smadja
6Université de Paris, IAME, INSERM, F-75018 Paris, France
7AP-HP, Hôpital Bichat, Service de Maladies Infectieuses et Tropicales, F-75018 Paris, France
8National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julien Poissy
9Université de Lille, Inserm U1285, CHU Lille, Pôle de réanimation, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000, Lille, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Drifa Belhadi
6Université de Paris, IAME, INSERM, F-75018 Paris, France
10AP-HP, Hôpital Bichat, Département d’Épidémiologie, Biostatistique et Recherche Clinique, F-75018 Paris, France
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alpha Diallo
11ANRS-MIE, F-75013 Paris, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christelle Delmas
12Institut de Santé Publique, Pôle de recherche clinique, INSERM, F-75013 Paris, France
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juliette Saillard
11ANRS-MIE, F-75013 Paris, France
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aline Dechanet
13AP-HP, Hôpital Bichat, Unité de recherche clinique, F-75018 Paris, France
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire Fougerou
14CHU de Rennes, Université Rennes 1, Inserm CIC 1414, F-35000 Rennes, France
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Minh-Patrick Lê
15AP-HP, Hôpital Bichat Claude Bernard, Laboratoire de pharmacologie-toxicologie, F-75018 Paris, France
16Université de Paris, INSERM, UMRS 1144, F-75006, Paris, France
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gilles Peytavin
6Université de Paris, IAME, INSERM, F-75018 Paris, France
15AP-HP, Hôpital Bichat Claude Bernard, Laboratoire de pharmacologie-toxicologie, F-75018 Paris, France
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noémie Mercier
11ANRS-MIE, F-75013 Paris, France
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Priyanka Velou
13AP-HP, Hôpital Bichat, Unité de recherche clinique, F-75018 Paris, France
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sarah Tubiana
6Université de Paris, IAME, INSERM, F-75018 Paris, France
17AP-HP, Hôpital Bichat, Centre de ressources biologiques, F-75018 Paris, France
PharmD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xavier Lescure
6Université de Paris, IAME, INSERM, F-75018 Paris, France
7AP-HP, Hôpital Bichat, Service de Maladies Infectieuses et Tropicales, F-75018 Paris, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emmanuel Faure
18Université de Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saad Nseir
9Université de Lille, Inserm U1285, CHU Lille, Pôle de réanimation, CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, F-59000, Lille, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Christophe Richard
19Hospices Civils de Lyon, Hôpital de la Croix-Rousse, Service de réanimation médicale, F-69000, Lyon, France
20Université Lyon I, CREATIS, CNRS UMR5220, Inserm U1044, INSA, F-69000, Lyon, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florent Wallet
21Hospices Civils de Lyon, Hôpital Lyon Sud, Service de soins critiques, F-69495 Pierre-Bénite, France
22Université Claude Bernard Lyon 1, PHE3ID, CIRI, INSERM U1111, CNRS UMR5308, ENS Lyon, F-69372, Lyon, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François Goehringer
23Université de Lorraine, CHRU de Nancy, Service des Maladies Infectieuses et Tropicales, F-54000 Nancy, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Lefèvre
23Université de Lorraine, CHRU de Nancy, Service des Maladies Infectieuses et Tropicales, F-54000 Nancy, France
24Université de Lorraine, APEMAC, F-54000 Nancy, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antoine Kimmoun
25Université de Lorraine, CHRU de Nancy, Service de Médecine Intensive et Réanimation Brabois, INSERM U1116, F-CRIN INI CRCT, F-54000 Nancy, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François Raffi
26CHU de Nantes, Hôpital Hôtel-Dieu, Département des Maladies Infectieuses, F-44093 Nantes, France
27CHU de Nantes, Inserm CIC-EC 1413, F-44093 Nantes, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Gaborit
26CHU de Nantes, Hôpital Hôtel-Dieu, Département des Maladies Infectieuses, F-44093 Nantes, France
27CHU de Nantes, Inserm CIC-EC 1413, F-44093 Nantes, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean Reignier
28CHU de Nantes, Service de Médecine Intensive et Réanimation, Université de Nantes, F-44093 Nantes, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Philippe Lanoix
29CHU Amiens-Picardie, Hôpital Nord, Service de maladies infectieuses et tropicales, F-80000 Amiens, France
30Université Picardie Jules Verne, AGIR UR UPJV 4294, CURS, F-80000 Amiens, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claire Andrejak
31CHU Amiens-Picardie, Département de Pneumologie, F-80000 Amiens, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoann Zerbib
32CHU Amiens-Picardie, Département de Réanimation Médicale, F-80000 Amiens, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Firouzé Bani-Sadr
33CHU de Reims, Département de Médecine Interne et Maladies Infectieuses, F-51092 Reims, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno Mourvilliers
34CHU de Reims, Service de Réanimation Médicale, F-51092 Reims, France
35Université de Reims Champagne-Ardenne, F-51092 Reims, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François Danion
36Hôpitaux Universitaires de Strasbourg, Département de maladies infectieuses et tropicales, F-67091 Strasbourg. France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yvon Ruch
36Hôpitaux Universitaires de Strasbourg, Département de maladies infectieuses et tropicales, F-67091 Strasbourg. France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raphaël Clere-Jehl
37Hôpitaux Universitaires de Strasbourg, Nouvel Hôpital Civil, Service de Médecine Intensive-Réanimation, F-67091 Strasbourg, Cedex, France
38Université de Strasbourg, ImmunoRhumatologie Moléculaire, INSERM UMR_S1109, LabEx TRANSPLANTEX, Centre de Recherche d’Immunologie et d’Hématologie, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg, F-67091 Strasbourg, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Le Moing
39CHU de Montpellier, Service des Maladies Infectieuses et Tropicales, F-34295 Montpellier, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kada Klouche
40CHU de Montpellier, Service de Médecine Intensive Réanimation, F-34295 Montpellier, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karine Lacombe
41Sorbonne Université, Inserm, Institut Pierre-Louis d’Épidémiologie et de Santé Publique, F-75013, Paris, France
42APHP, Hôpital Saint-Antoine, Service de maladies infectieuses et tropicales, F-75012 Paris, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillaume Martin-Blondel
43CHU de Toulouse, Service des maladies infectieuses et Tropicales, F-31320 Toulouse, France
44Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity) INSERM UMR1291 - CNRS UMR5051 - Université Toulouse III, F-31320 Toulouse, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fanny Vardon-Bounes
45CHU de Toulouse, Département d’anesthésie et de soins intensifs, F-31300 Toulouse, France
46Université Toulouse 3 Paul Sabatier, Inserm U1297, F-31300 Toulouse, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
André Cabié
47PCCEI, Univ Montpellier, Univ Antilles, Inserm, EFS, F-34394 Montpellier, France
48CHU de Martinique, Service des maladies infectieuses et tropicales, Inserm CIC1424, F-97200 Fort de France, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-Marie Turmel
48CHU de Martinique, Service des maladies infectieuses et tropicales, Inserm CIC1424, F-97200 Fort de France, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lionel Piroth
49CHU de Dijon, Département de Maladies Infectieuses, F-21000, Dijon, France
50Université Bourgogne Franche-Comté, CIC 1432, INSERM, F-21000, Dijon, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathieu Blot
49CHU de Dijon, Département de Maladies Infectieuses, F-21000, Dijon, France
51Inserm, LNC UMR 1231, FCS Bourgogne-Franche Comté LipSTIC LabEx, F-21000, Dijon, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Élisabeth Botelho-Nevers
52CHU de Saint-Etienne, Service d’Infectiologie, F-42055 Saint-Etienne, France
53Université Jean Monnet, Université Claude Bernard Lyon 1, GIMAP, CIRI, INSERM U1111, CNRS UMR5308, ENS Lyon, F-42023 Saint-Etienne, France
54CIC 1408, INSERM, F-42055 Saint-Etienne, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amandine Gagneux-Brunon
52CHU de Saint-Etienne, Service d’Infectiologie, F-42055 Saint-Etienne, France
53Université Jean Monnet, Université Claude Bernard Lyon 1, GIMAP, CIRI, INSERM U1111, CNRS UMR5308, ENS Lyon, F-42023 Saint-Etienne, France
54CIC 1408, INSERM, F-42055 Saint-Etienne, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guillaume Thiery
55CHU de Saint-Etienne, Service de Réanimation Médicale, F-42055 Saint-Etienne, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François Bénézit
56CHU de Rennes, Hôpital Pontchaillou, Service de maladies infectieuses et de soins intensifs, F-35000 Rennes, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rostane Gaci
57CHR Metz-Thionville, Hôpital de Mercy, Service de réanimation polyvalente, F-57530 Ars-Laquenexy, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joy Mootien
58Groupe Hospitalier de la région Mulhouse Sud-Alsace, Service de réanimation médicale, F-68100 Mulhouse, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sébastien Gallien
59APHP, Hôpital Henri Mondor, Département de maladies infectieuses, F-94000 Créteil, France
60INSERM U955, Team 16, IMRB Créteil, Créteil, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Denis Garot
61CHRU Tours, Service de Médecine Intensive Réanimation, F-37044 Tours, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin Bouiller
62Centre Hospitalier Universitaire Besançon, Service des maladies infectieuses et tropicales, F-25030 Besançon, France
63UMR-CNRS 6249 Chrono-environnement, Université Bourgogne Franche-Comté, F-25000 Besançon, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Loïc Epelboin
64Centre Hospitalier de Cayenne Andrée Rosemon, Unité des Maladies Infectieuses et Tropicales, F-97300 Cayenne, France
65Centre Hospitalier de Cayenne Andrée Rosemon, Centre d’Investigation Clinique 1424, Inserm, F-97300 Cayenne, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stéphane Jauréguiberry
66AP-HP, Hôpital Bicêtre, Service des maladies infectieuses, F-94270 Le Kremlin Bicêtre, France
67AP-HP, Centre National de Référence du Paludisme, Paris, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandre Gaymard
3Hospices Civils de Lyon, Laboratoire de Virologie, Institut des Agents Infectieux de Lyon, Centre National de Référence des virus respiratoires France Sud, F-69317, Lyon, France
4Université Claude Bernard Lyon 1, Virpath, CIRI, INSERM U1111, CNRS UMR5308, ENS Lyon, F-69372, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexandre Gaymard
Gil Verschelden
5Cliniques Universitaires de Bruxelles – Hôpital Érasme, Université Libre de Bruxelles, Clinique des maladies infectieuses, Brussels, Belgium
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sandra Braz
68Centro Hospitalar Universitário Lisboa Norte, Hospital De Santa Maria, Department of Internal Medicine, P-1649-035 Lisbon, Portugal
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joao Miguel Ferreira Ribeiro
69Centro Hospitalar Universitário Lisboa Norte, Hospital De Santa Maria, Department of Intensive Care Medicine, P-1649-035 Lisbon, Portugal
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Joannidis
70Division of Intensive Care and Emergency Medicine, Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thérèse Staub
71Centre hospitalier de Luxembourg, Service des maladies infectieuses, L-1210 Luxembourg, Luxembourg
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antoine Altdorfer
72Infectious Diseases Department, CHR de la Citadelle, Liège, Belgium
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Greil
73Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Salzburg, 5020 Salzburg, Austria
74Cancer Cluster Salzburg, 5020, Salzburg, Austria
75AGMT, 5020 Salzburg, Austria
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Egle
73Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute - Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University Salzburg, 5020 Salzburg, Austria
74Cancer Cluster Salzburg, 5020, Salzburg, Austria
75AGMT, 5020 Salzburg, Austria
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jérémie Guedj
6Université de Paris, IAME, INSERM, F-75018 Paris, France
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marion Noret
76RENARCI, Réseau national de recherche clinique en infectiologie, France
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberto Roncon-Albuquerque
77Centro Hospitalar São João, Emergency and Intensive Care Department, Porto, Portugal
78Universidade do Porto, Faculty of Medicine, Porto, Portugal
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose-Artur Paiva
77Centro Hospitalar São João, Emergency and Intensive Care Department, Porto, Portugal
78Universidade do Porto, Faculty of Medicine, Porto, Portugal
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno Lina
3Hospices Civils de Lyon, Laboratoire de Virologie, Institut des Agents Infectieux de Lyon, Centre National de Référence des virus respiratoires France Sud, F-69317, Lyon, France
4Université Claude Bernard Lyon 1, Virpath, CIRI, INSERM U1111, CNRS UMR5308, ENS Lyon, F-69372, Lyon, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominique Costagliola
41Sorbonne Université, Inserm, Institut Pierre-Louis d’Épidémiologie et de Santé Publique, F-75013, Paris, France
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yazdan Yazdanpanah
6Université de Paris, IAME, INSERM, F-75018 Paris, France
7AP-HP, Hôpital Bichat, Service de Maladies Infectieuses et Tropicales, F-75018 Paris, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles Burdet
6Université de Paris, IAME, INSERM, F-75018 Paris, France
10AP-HP, Hôpital Bichat, Département d’Épidémiologie, Biostatistique et Recherche Clinique, F-75018 Paris, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
France Mentré
6Université de Paris, IAME, INSERM, F-75018 Paris, France
10AP-HP, Hôpital Bichat, Département d’Épidémiologie, Biostatistique et Recherche Clinique, F-75018 Paris, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The antiviral efficacy of remdesivir is still controversial. We aimed at evaluating its clinical effectiveness in hospitalised patients with COVID-19, with indication of oxygen and/or ventilator support. Following prior publication of preliminary results, here we present the final results after completion of data monitoring.

Methods In this European multicentre, open-label, parallel-group, randomised, controlled trial (DisCoVeRy, NCT04315948; EudraCT2020-000936-23), participants were randomly allocated to receive usual standard of care (SoC) alone or in combination with remdesivir, lopinavir/ritonavir, lopinavir/ritonavir and IFN-β-1a, or hydroxychloroquine. Adult patients hospitalised with COVID-19 were eligible if they had clinical evidence of hypoxemic pneumonia, or required oxygen supplementation. Exclusion criteria included elevated liver enzyme, severe chronic kidney disease, any contra-indication to one of the studied treatments or their use in the 29 days before randomization, or use of ribavirin, as well as pregnancy or breast-feeding. Here, we report results for remdesivir + SoC versus SoC alone. Remdesivir was administered as 200 mg infusion on day 1, followed by once daily infusions of 100 mg up to 9 days, for a total duration of 10 days. It could be stopped after 5 days if the participant was discharged. Treatment assignation was performed via web-based block randomisation stratified on illness severity and administrative European region. The primary outcome was the clinical status at day 15 measured by the WHO 7-point ordinal scale, assessed in the intention-to-treat population.

Findings Between March 22nd, 2020 and January 21st, 2021, 857 participants were randomised to one of the two arms in 5 European countries and 843 participants were included for the evaluation of remdesivir (control, n=423; remdesivir, n=420).

At day 15, the distribution of the WHO ordinal scale was as follow in the remdesivir and control groups, respectively: Not hospitalized, no limitations on activities: 62/420 (14.8%) and 72/423 (17.0%); Not hospitalized, limitation on activities: 126/420 (30%) and 135/423 (31.9%); Hospitalized, not requiring supplemental oxygen: 56/420 (13.3%) and 31/423 (7.3%); Hospitalized, requiring supplemental oxygen: 75/420 (17.9%) and 65/423 (15.4%); Hospitalized, on non-invasive ventilation or high flow oxygen devices: 16/420 (3.8%) and 16/423 (3.8%); Hospitalized, on invasive mechanical ventilation or ECMO: 64/420 (15.2%) and 80/423 (18.9%); Death: 21/420 (5%) and 24/423 (5.7%). The difference between treatment groups was not statistically significant (OR for remdesivir, 1.02, 95% CI, 0.62 to 1.70, P=0.93). There was no significant difference in the occurrence of Serious Adverse Events between treatment groups (remdesivir, n=147/410, 35.9%, versus control, n=138/423, 32.6%, p=0.29).

Interpretation Remdesivir use for the treatment of hospitalised patients with COVID-19 was not associated with clinical improvement at day 15.

Funding European Union Commission, French Ministry of Health, DIM One Health Île-de-France, REACTing, Fonds Erasme-COVID-ULB; Belgian Health Care Knowledge Centre (KCE), AGMT gGmbH, FEDER “European Regional Development Fund”, Portugal Ministry of Health, Portugal Agency for Clinical Research and Biomedical Innovation. Remdesivir was provided free of charge by Gilead.

Competing Interest Statement

Dr. Costagliola reports grants and personal fees from Janssen, personal fees from Gilead, outside the submitted work. Dr. Mentre reports grants from INSERM Reacting (French Government), grants from Ministry of Health (French Government), grants from European Commission, during the conduct of the study; grants from Sanofi, grants from Roche, outside the submitted work. Dr. Hites reports grants from The Belgian Center for Knowledge (KCE), grants from Fonds Erasme-COVID-ULB, during the conduct of the study; personal fees from Gilead, outside the submitted work. Dr. Mootien reports non-financial support from GILEAD, outside the submitted work. Dr. Gaborit reports non-financial support from Gilead, non-financial support from MSD, outside the submitted work. Dr. Botelho-Nevers reports other from Pfizer, other from Janssen, outside the submitted work. Dr. Lacombe reports personal fees and non-financial support from Gilead, personal fees and non-financial support from Janssen, personal fees and non-financial support from MSD, personal fees and non-financial support from ViiV Healthcare, personal fees and non-financial support from Abbvie, during the conduct of the study. Dr. Wallet reports personal fees and non-financial support from Jazz pharmaceuticals, personal fees and non-financial support from Novartis, personal fees and non-financial support from Kite-Gilead, outside the submitted work. Dr. Kimmoun reports personal fees from Aguettan, personal fees from Aspen, outside the submitted work. Dr. Thiery reports personal fees from AMGEN, outside the submitted work. Dr. Burdet reports personal fees from Da Volterra, personal fees from Mylan Pharmaceuticals, outside the submitted work. Dr. Poissy reports personal fees from Gilead for lectures, outside the submitted work. Dr. Goehringer reports personal fees from Gilead Sciences, non-financial support from Gilead Sciences, grants from Biomerieux, non-financial support from Pfizer, outside the submitted work. Dr. Peytavin reports personal fees from Gilead Sciences, personal fees from Merck France, personal fees from ViiV Healthcare, personal fees from TheraTechnologies, outside the submitted work. Dr. Danion reports personal fees from Gilead, outside the submitted work. Dr. Raffi reports personal fees from Gilead, personal fees from Janssen, personal fees from MSD, personal fees from Abbvie, personal fees from ViiV Healthcare, personal fees from Theratechnologies, personal fees from Pfizer, outside the submitted work. Dr. Gallien reports personal fees from Gilead, personal fees from Pfizer, personal fees from ViiV, personal fees from MSD, outside the submitted work; and has received consulting fee from Gilead in August 2020 to check the registration file of remdesivir for the French administration. Dr. Nseir reports personal fees from MSD, personal fees from Pfizer, personal fees from Gilead, personal fees from Biomerieux, personal fees from BioRad, outside the submitted work. Dr. Lefevre reports personal fees from Mylan, personal fees from Gilead, outside the submitted work. Dr. Guedj reports personal fees from Roche, outside the submitted work. Other authors have nothing to disclose.

Clinical Trial

NCT04315948

Funding Statement

This work received funding from several sources: Europe: European Union Horizon 2020 research and innovation programme Austria: AGMT gGmbH Belgium: Belgian Health Care Knowledge Centre; Fonds Erasme-COVID-ULB France: REACTing, a French multi-disciplinary collaborative network working on emerging infectious diseases; Ministry of Health; Paris Ile-de-France Region Luxemburg: European Regional Development Fund Portugal: Ministry of Health; Agency for Clinical Research and Biomedical Innovation Remdesivir was provided by Gilead free of charge.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Centre de Protection des Personnes Ile-de-France-III, approval #20.03.06.51744

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* co-second authors

  • ↵** co-before-last authors

  • ↵*** co-last authors

  • ↵# on behalf of the DisCoVeRy Study Group

  • We corrected the mortality at day 28. In the first submitted version, an error occured and day 29 mortality was presented.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 12, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial
Florence Ader, Maude Bouscambert-Duchamp, Maya Hites, Nathan Peiffer-Smadja, Julien Poissy, Drifa Belhadi, Alpha Diallo, Christelle Delmas, Juliette Saillard, Aline Dechanet, Claire Fougerou, Minh-Patrick Lê, Gilles Peytavin, Noémie Mercier, Priyanka Velou, Sarah Tubiana, Xavier Lescure, Emmanuel Faure, Saad Nseir, Jean-Christophe Richard, Florent Wallet, François Goehringer, Benjamin Lefèvre, Antoine Kimmoun, François Raffi, Benjamin Gaborit, Jean Reignier, Jean-Philippe Lanoix, Claire Andrejak, Yoann Zerbib, Firouzé Bani-Sadr, Bruno Mourvilliers, François Danion, Yvon Ruch, Raphaël Clere-Jehl, Vincent Le Moing, Kada Klouche, Karine Lacombe, Guillaume Martin-Blondel, Fanny Vardon-Bounes, André Cabié, Jean-Marie Turmel, Lionel Piroth, Mathieu Blot, Élisabeth Botelho-Nevers, Amandine Gagneux-Brunon, Guillaume Thiery, François Bénézit, Rostane Gaci, Joy Mootien, Sébastien Gallien, Denis Garot, Kevin Bouiller, Loïc Epelboin, Stéphane Jauréguiberry, Alexandre Gaymard, Gil Verschelden, Sandra Braz, Joao Miguel Ferreira Ribeiro, Michael Joannidis, Thérèse Staub, Antoine Altdorfer, Richard Greil, Alexander Egle, Jérémie Guedj, Marion Noret, Roberto Roncon-Albuquerque, Jose-Artur Paiva, Bruno Lina, Dominique Costagliola, Yazdan Yazdanpanah, Charles Burdet, France Mentré
medRxiv 2022.03.30.22273206; doi: https://doi.org/10.1101/2022.03.30.22273206
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Remdesivir for the treatment of hospitalised patients with COVID-19: final results from the DisCoVeRy randomised, controlled, open-label trial
Florence Ader, Maude Bouscambert-Duchamp, Maya Hites, Nathan Peiffer-Smadja, Julien Poissy, Drifa Belhadi, Alpha Diallo, Christelle Delmas, Juliette Saillard, Aline Dechanet, Claire Fougerou, Minh-Patrick Lê, Gilles Peytavin, Noémie Mercier, Priyanka Velou, Sarah Tubiana, Xavier Lescure, Emmanuel Faure, Saad Nseir, Jean-Christophe Richard, Florent Wallet, François Goehringer, Benjamin Lefèvre, Antoine Kimmoun, François Raffi, Benjamin Gaborit, Jean Reignier, Jean-Philippe Lanoix, Claire Andrejak, Yoann Zerbib, Firouzé Bani-Sadr, Bruno Mourvilliers, François Danion, Yvon Ruch, Raphaël Clere-Jehl, Vincent Le Moing, Kada Klouche, Karine Lacombe, Guillaume Martin-Blondel, Fanny Vardon-Bounes, André Cabié, Jean-Marie Turmel, Lionel Piroth, Mathieu Blot, Élisabeth Botelho-Nevers, Amandine Gagneux-Brunon, Guillaume Thiery, François Bénézit, Rostane Gaci, Joy Mootien, Sébastien Gallien, Denis Garot, Kevin Bouiller, Loïc Epelboin, Stéphane Jauréguiberry, Alexandre Gaymard, Gil Verschelden, Sandra Braz, Joao Miguel Ferreira Ribeiro, Michael Joannidis, Thérèse Staub, Antoine Altdorfer, Richard Greil, Alexander Egle, Jérémie Guedj, Marion Noret, Roberto Roncon-Albuquerque, Jose-Artur Paiva, Bruno Lina, Dominique Costagliola, Yazdan Yazdanpanah, Charles Burdet, France Mentré
medRxiv 2022.03.30.22273206; doi: https://doi.org/10.1101/2022.03.30.22273206

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (551)
  • Anesthesia (135)
  • Cardiovascular Medicine (1751)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (312)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (656)
  • Epidemiology (10790)
  • Forensic Medicine (8)
  • Gastroenterology (585)
  • Genetic and Genomic Medicine (2939)
  • Geriatric Medicine (287)
  • Health Economics (532)
  • Health Informatics (1921)
  • Health Policy (833)
  • Health Systems and Quality Improvement (744)
  • Hematology (291)
  • HIV/AIDS (628)
  • Infectious Diseases (except HIV/AIDS) (12508)
  • Intensive Care and Critical Care Medicine (687)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2789)
  • Nursing (151)
  • Nutrition (432)
  • Obstetrics and Gynecology (556)
  • Occupational and Environmental Health (597)
  • Oncology (1460)
  • Ophthalmology (443)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (363)
  • Primary Care Research (336)
  • Psychiatry and Clinical Psychology (2635)
  • Public and Global Health (5349)
  • Radiology and Imaging (1007)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (725)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)